108 related articles for article (PubMed ID: 1296980)
1. Methylprednisolone reduces the nephrotoxicity caused by cisplatin.
Uozumi J; Koikawa Y; Ueda T
J Pharmacobiodyn; 1992 Dec; 15(12):693-7. PubMed ID: 1296980
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic effect of methylprednisolone against cisplatin-induced nephrotoxicity in rats.
Koikawa Y; Uozumi J; Ueda T; Yasumasu T; Kumazawa J
Toxicol Lett; 1993 Mar; 66(3):281-5. PubMed ID: 8475508
[TBL] [Abstract][Full Text] [Related]
3. [Prophylactic effect of methylprednisolone on cisplatin-induced nephrotoxicity in rats].
Koikawa Y; Uozumi J; Yasumasu T; Ueda T; Kumazawa J
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1363-7. PubMed ID: 8346934
[TBL] [Abstract][Full Text] [Related]
4. [Prophylactic effect of methylprednisolone on cisplatin-induced nephrotoxicity].
Koikawa Y
Fukuoka Igaku Zasshi; 1995 Feb; 86(2):31-9. PubMed ID: 7729781
[TBL] [Abstract][Full Text] [Related]
5. The protective effect of methylprednisolone against cisplatin-induced nephrotoxicity in patients with urothelial tumors.
Uozumi J; Koikawa Y; Yasumasu T; Tokuda N; Kumazawa J
Int J Urol; 1996 Sep; 3(5):343-7. PubMed ID: 8886909
[TBL] [Abstract][Full Text] [Related]
6. The role of the renin-angiotensin system in cisplatin nephrotoxicity.
Deegan PM; Nolan C; Ryan MP; Basinger MA; Jones MM; Hande KR
Ren Fail; 1995 Nov; 17(6):665-74. PubMed ID: 8771239
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the possible role of iron and copper in cisplatin-induced nephrotoxicity in the rat.
Goudie J; Chandra M; Lawrence GD; Williams P
Res Commun Chem Pathol Pharmacol; 1994 Jan; 83(1):33-49. PubMed ID: 8165368
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of N-benzoyl amino acids on cisplatin nephrotoxicity in rats.
Tokunaga J; Kobayashi M; Kitagawa A; Nakamura C; Arimori K; Nakano M
Biol Pharm Bull; 1996 Nov; 19(11):1451-6. PubMed ID: 8951163
[TBL] [Abstract][Full Text] [Related]
9. Nordihydroguaiaretic acid ameliorates cisplatin induced nephrotoxicity and potentiates its anti-tumor activity in DMBA induced breast cancer in female Sprague-Dawley rats.
Mundhe NA; Kumar P; Ahmed S; Jamdade V; Mundhe S; Lahkar M
Int Immunopharmacol; 2015 Sep; 28(1):634-42. PubMed ID: 26247680
[TBL] [Abstract][Full Text] [Related]
10. Comparative nephrotoxicity of tetraplatin and cisplatin in rats.
Rahman A; Roh JK; Preuss HG
Nephron; 1993; 64(2):289-95. PubMed ID: 8321364
[TBL] [Abstract][Full Text] [Related]
11. The effect of methylprednisolone on cisplatin-induced nephrotoxicity in rat renal cortical slices.
Uozumi J; Koikawa Y; Yasumasu T; Ueda T; Kumazawa J
Res Exp Med (Berl); 1995; 195(4):231-5. PubMed ID: 8525073
[TBL] [Abstract][Full Text] [Related]
12. Effects of a cisplatin-chondroitin sulfate A complex in reducing the nephrotoxicity of cisplatin.
Zhang JS; Imai T; Otagiri M
Arch Toxicol; 2000 Aug; 74(6):300-7. PubMed ID: 11005675
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats.
Yasumasu T; Ueda T; Uozumi J; Mihara Y; Kumazawa J
Pharmacol Toxicol; 1992 Feb; 70(2):143-7. PubMed ID: 1508841
[TBL] [Abstract][Full Text] [Related]
14. The effect of methylprednisolone on platinum kinetics and urinary enzyme excretion following intravenous cisplatin in vivo and on the growth inhibition of LLC-PK1 cells by cisplatin in vitro.
Uozumi J; Koikawa Y; Yasumasu T; Tokuda N; Ueda T; Kumazawa J
Res Exp Med (Berl); 1996; 196(4):211-7. PubMed ID: 8903096
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of cisplatin nephrotoxicity with glycine: dose dependency in rats.
Li Q; Bowmer CJ; Yates MS
J Pharm Pharmacol; 1995 Mar; 47(3):223-6. PubMed ID: 7602485
[TBL] [Abstract][Full Text] [Related]
16. Effects of dosing time and schedule on cisplatin-induced nephrotoxicity in rats.
Kobayashi M; To H; Yuzawa M; Hakamata Y; Higuchi S; Tokue A; Fujimura A; Kobayashi E
J Pharm Pharmacol; 2000 Oct; 52(10):1233-7. PubMed ID: 11092567
[TBL] [Abstract][Full Text] [Related]
17. Early and quantitative detection of cisplatin-induced nephrotoxicity by measurement of plasma PSP (phenolsulfonphthalein) half-life in rats.
Uozumi J; Ueda T; Koikawa Y; Yasumasu T; Kumazawa J
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):901-4. PubMed ID: 8254999
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of the ethanol extract of the roots of Brassica rapa on cisplatin-induced nephrotoxicity in LLC-PK1 cells and rats.
Kim YH; Kim YW; Oh YJ; Back NI; Chung SA; Chung HG; Jeong TS; Choi MS; Lee KT
Biol Pharm Bull; 2006 Dec; 29(12):2436-41. PubMed ID: 17142978
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of safranal to cisplatin-induced nephrotoxicity.
Karafakıoğlu YS; Bozkurt MF; Hazman Ö; Fıdan AF
Biochem J; 2017 Mar; 474(7):1195-1203. PubMed ID: 28188255
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vivo evaluations of curcumin and its analog difluorinated curcumin against cisplatin-induced nephrotoxicity.
Sahin K; Orhan C; Tuzcu M; Muqbil I; Sahin N; Gencoglu H; Guler O; Padhye SB; Sarkar FH; Mohammad RM
Biol Trace Elem Res; 2014 Feb; 157(2):156-63. PubMed ID: 24415068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]